Evidence map›Paper›PMID 24299467›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2013

Antibiotic exposure in the first two years of life and development of asthma and other allergic diseases by 7.5 yr: a dose-dependent relationship.

Lauren Hoskin-Parr, Alison Teyhan, Ariel Blocker, A J W Henderson

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03229863 (The Infant MiND Study), which is not on this map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03229863 naactive not recruitingnot on this mapstarted 2017, after this paper: background citation

The Infant MiND Study: An Examination of Infants' Microbiome, Nutrition, and Development Study.

TypeinterventionalSponsorUniversity of California, DavisRan2017 to 2027Enrolled102ConditionsMicrobial Colonization, Infant DevelopmentArmsSweet Potatos, Pears
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Multidrug-resistantERJ open research · 2026
    Article
  8. Article
  9. Article
  10. Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence.The journal of allergy and clinical immunology. In practice · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Delivery mode and risk of gastrointestinal disease in the offspring.Acta obstetricia et gynecologica Scandinavica · 2022
    Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lauren Hoskin-ParrSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Alison Teyhan
Ariel Blocker
A J W Henderson
University of Bristol · GB

Funding

Medical Research Council G9815508Wellcome Trust 092731
6 · The paper itself

Abstract

backgroundAntibiotic use in infancy disrupts gut microflora during a critical period for immune system development. It is hypothesized that this could predispose to the development of allergic diseases. We investigated the associations of antibiotic use in the first 2 yr of life with the development of asthma, eczema or hay fever by age 7.5 yr in a longitudinal birth cohort.

methodsSubjects were 4952 children from the Avon Longitudinal Study of Parents and Children (ALSPAC). Child antibiotic use and asthma, eczema and hay fever symptoms were maternally reported. Atopy was assessed by skin prick tests at age 7.5 yr. The total number of antibiotic courses was considered as the main exposure. Data were analysed using multivariate logistic regression.

resultsChildren reported to have taken antibiotics during infancy (0-2 yr) were more likely to have asthma at 7.5 yr (OR 1.75, 95% CI 1.40-2.17), and the odds (OR, [95% CI]) increased with greater numbers of courses: once 1.11 [0.84-1.48]; twice 1.50 [1.14-1.98]; three times 1.79 [1.34-2.40]; four times or more 2.82 [2.19-3.63]. Increased antibiotic use was also associated with higher odds of eczema and hay fever but not atopy. The effect appeared to be associated with cumulative rather than a critical period of exposure during the first 2 yr.

conclusionsA robust and dose-dependent association was found between antibiotic use in the first 2 yr of life and asthma at age 7.5 yr but did not appear to be mediated through an association with atopy.

Indexed as

Age FactorsAnti-Bacterial AgentsAsthmaChildCohort StudiesDose-Response Relationship, ImmunologicEczemaFemaleHumansInfantInfant, NewbornLongitudinal StudiesMaleRiskSkin TestsAnti-Bacterial AgentsantibioticsatopyAvon Longitudinal Study of Parents and Childrenchildhood asthmaeczemahay feverwheeze

Identifiers

PMID24299467
PMCPMC3995010
OpenAlexW2049669395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.